Top

BMC Public Health

Published in:

01-12-2021 | Coronavirus | Research article

Analyzing disparities in COVID-19 testing trends according to risk for COVID-19 severity across New York City

Authors: Wil Lieberman-Cribbin, Naomi Alpert, Raja Flores, Emanuela Taioli

Published in: BMC Public Health | Issue 1/2021

Abstract

Background

Given the interplay between race and comorbidities on COVID-19 morbidity and mortality, it is vital that testing be performed in areas of greatest need, where more severe cases are expected. The goal of this analysis is to evaluate COVID-19 testing data in NYC relative to risk factors for COVID-19 disease severity and demographic characteristics of NYC neighborhoods.

Methods

COVID-19 testing and the racial/ethnic composition of NYC Zip Code Tabulation Areas (ZCTA) were obtained from the NYC Coronavirus data repository and the American Community Survey, respectively. The prevalence of neighborhood-level risk factors for COVID-19 severity according to the Centers for Disease Control and Prevention criteria for risk of severe illness and complications from COVID-19 were used to create a ZCTA-level risk index. Poisson regressions were performed to study the ratio of total tests relative to the total ZCTA population and the proportion of positive tests relative to the total tests performed over time.

Results

From March 2nd-April 6th, the total tests/population (%) was positively associated with the proportion of white residents (IRR_adj: 1.0003, 95% CI: 1.0003–1.0004) and the COVID risk index (IRR_adj: 1.038, 95% CI: 1.029–1.046). The risk index (IRR_adj: 1.017, 95% CI: 0.939–1.101) was not associated with total tests performed from April 6th-May 12th, and inversely associated from May 12th-July 6th (IRR_adj: 0.862, 95% CI: 0.814–0.913). From March 2nd-April 6th the COVID risk index was not statistically associated (IRR_adj: 1.010, 95% CI: 0.987–1.034) with positive tests/total tests. From April 6th-May 12th, the COVID risk index was positively associated (IRR_adj: 1.031, 95% CI: 1.002–1.060), while from May 12th-July 6th, the risk index was inversely associated (IRR_adj: 1.135, 95% CI: 1.042–1.237) with positivity.

Conclusions

Testing in NYC has suffered from the lack of availability in high-risk populations, and was initially limited as a diagnostic tool for those with severe symptoms, which were mostly concentrated in areas where vulnerable residents live. Subsequent time periods of testing were not targeted in areas according to COVID-19 disease risk, as these areas still experience more positive tests.

World Health Organization. (2021). Coronavirus disease 2019 (COVID-19) 8 June 2021 Weekly Epidemiological Update. Retrieved from https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19%2D%2D-8-june-2021

Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4. https://doi.org/10.1016/S1473-3099(20)30120-1.CrossRefPubMedPubMedCentral

NYC coronavirus disease 2019 (COVID-19) data. New York City Department of Health. https://github.com/nychealth/coronavirus-data. Updated daily.

Patel, Neel (2020). Why the CDC botched its coronavirus testing. MIT technology review. Retrieved from https://www.technologyreview.com/2020/03/05/905484/why-the-cdc-botched-its-coronavirus-testing/

Shear MD, Goodnough a, Kaplan S, fink S, Thomas K, and Weiland N. the lost month: how a failure to test blinded the US to COVID-19. The New York times. https://www.nytimes.com/2020/03/28/us/testing-coronavirus-pandemic.html. Published March 28, 2020. Updated April 1, 2020. Accessed 13 April 2020.

Press Office of Governor Andrew W Cuomo. Governor Cuomo Sings the ‘New York State on PAUSE’ Executive Order. New York State. https://www.governor.ny.gov/news/governor-cuomo-signs-new-york-state-pause-executive-order. Published March 20, 2020. Accessed 3 Sept 2020.

Chowkwanyun M, Reed AL Jr. Racial health disparities and Covid-19—caution and context. N Engl J Med. 2020;6(3):201–3. https://doi.org/10.1056/NEJMp2012910.CrossRef

Wadhera RK, Wadhera P, Gaba P, Figueroa JF, Maddox KEJ, Yeh RW, et al. Variation in COVID-19 hospitalizations and deaths across New York City boroughs. JAMA. 2020;323(21):2192–5. https://doi.org/10.1001/jama.2020.7197.CrossRefPubMedPubMedCentral

Lieberman-Cribbin W, Tuminello S, Flores RM, Taioli E. Disparities in COVID-19 testing and positivity in New York City. Am J Prev Med. 2020;59(3):326–32. https://doi.org/10.1016/j.amepre.2020.06.005.CrossRefPubMedPubMedCentral

10.

Karaye IM, Horney JA. The impact of social vulnerability on COVID-19 in the US: an analysis of spatially varying relationships. Am J Prev Med. 2020;59(3):317–25. https://doi.org/10.1016/j.amepre.2020.06.006.CrossRefPubMedPubMedCentral

11.

Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002;94(8):666–8.PubMedPubMedCentral

12.

Yancy CW. COVID-19 and African Americans. JAMA. 2020.

13.

New York State Department of Health (2020). NYS Fatalities by County. Retrieved from https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Fatalities?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n#/views/NYS%2dCOVID19%2dTracker/NYSDOHCOVID%2d19Tracker%2dMap?%253Aembed=yes&%253Atoolbar=no). Accessed 04/28/2020.

14.

Jordan R E, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198. https://doi.org/10.1136/bmj.m1198.

15.

COVID C, Team R. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343–6. https://doi.org/10.15585/mmwr.mm6912e2.CrossRef

16.

Rosenberg ES, Dufort EM, Blog DS, Hall EW, Hoefer D, Backenson BP, et al. COVID-19 testing, epidemic features, hospital outcomes, and household prevalence, New York state—March 2020. Clin Infect Dis. 2020;71(8):1953–9. https://doi.org/10.1093/cid/ciaa549.CrossRefPubMed

17.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020.

18.

Centers for Disease Control and Prevention. Coronavrius Disease 2019 (COVID-19) People Who Are at Increased Risk for Severe Illness. Updated June 25, 2020. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-increased-risk.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fneed-extra-precautions%2Fpeople-at-higher-risk.html

19.

Raifman MA, Raifman JR. Disparities in the population at risk of severe illness from COVID-19 by race/ethnicity and income. Am J Prev Med. 2020;59(1):137–9. https://doi.org/10.1016/j.amepre.2020.04.003.CrossRefPubMedPubMedCentral

20.

Razzaghi H, Wang Y, Lu H, Marshall KE, Dowling NF, Paz-Bailey G, et al. Estimated county-level prevalence of selected underlying medical conditions associated with increased risk for severe COVID-19 illness—United States, 2018. Morb Mortal Wkly Rep. 2020;69(29):945–50. https://doi.org/10.15585/mmwr.mm6929a1.CrossRef

21.

Lieberman-Cribbin W, Alpert N, Flores R, Taioli E. A risk index for COVID-19 severity is associated with COVID-19 mortality in nEw York City. BMC Public Health. 2021 Dec;21(1):1–8. https://doi.org/10.1186/s12889-021-11498-x.CrossRef

22.

Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. 500 Cities Project Data [online]. 2018 [Accessed Oct 23, 2018]. URL: https://www.cdc.gov/500cities.

23.

Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, [2017].

24.

New York City Department of Health and Mental Hygiene. EpiQuery. Accessed July 29, 2020. Available at https://nyc.gov/health/epiquery

25.

New York State Department of Health. Statewide Planning and Research Cooperative System (SPARCS). https://www.health.ny.gov/statistics/sparcs/

26.

New York City Department of Health. Environment & Health Data Portal. Heart Attack Hospitalizations. http://a816-dohbesp.nyc.gov/IndicatorPublic/VisualizationData.aspx?id=90,4466a0,13,Summarize.

27.

U.S. Census Bureau; American Community Survey, 2018 American Community Survey 5-Year Estimates, Tables B02001 and B03003. [Accessed 04/28/2020].

28.

United States Census Bureau. Relationship Files. Available at: https://www2.census.gov/geo/docs/maps-data/data/rel/zcta_tract_rel_10.txt

29.

New York City United Hospital Fund Codes. Available at https://www1.nyc.gov/assets/doh/downloads/pdf/ah/zipcodetable.pdf

30.

McElfish PA, Purvis R, James LP, Willis DE, Andersen JA. Perceived barriers to COVID-19 testing. Int J Environ Res Public Health. 2021;18(5):2278. https://doi.org/10.3390/ijerph18052278.CrossRefPubMedPubMedCentral

31.

Kim EJ, Marrast L, Conigliaro J. COVID-19: magnifying the effect of health disparities. J Gen Intern Med. 2020;35(8):2441–2. https://doi.org/10.1007/s11606-020-05881-4.CrossRefPubMedPubMedCentral

32.

Centers for Disease Control and Prevention (2020). COVID-19 in Racial and Ethnic Minority Groups. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/racial-ethnic-minorities.html

33.

Ou HT, Mukherjee B, Erickson SR, Piette JD, Bagozzi RP, Balkrishnan R. Comparative performance of comorbidity indices in predicting health care-related behaviors and outcomes among Medicaid enrollees with type 2 diabetes. Population health management. 2012;15(4):220–9. https://doi.org/10.1089/pop.2011.0037.CrossRefPubMedPubMedCentral

34.

Wu SL, Mertens AN, Crider YS, Nguyen A, Pokpongkiat NN, Djajadi S, Seth A, Hsiang MS, Colford JM, Reingold A, Arnold BF. Substantial underestimation of SARS-CoV-2 infection in the United States. Nat Commun 2020;11(1):1–0, 4507, DOI: https://doi.org/10.1038/s41467-020-18272-4.

Title: Analyzing disparities in COVID-19 testing trends according to risk for COVID-19 severity across New York City
Authors: Wil Lieberman-Cribbin
Naomi Alpert
Raja Flores
Emanuela Taioli
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Coronavirus
COVID-19
Published in: BMC Public Health / Issue 1/2021
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-021-11762-0

2024 ASCO Annual Meeting

Springer Medicine

Analyzing disparities in COVID-19 testing trends according to risk for COVID-19 severity across New York City

Abstract

Background

Methods

Results

Conclusions

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Correction to: Meaningful activities during COVID-19 lockdown and association with mental health in Belgian adults

Correction to: association between internal migration and epidemic dynamics: an analysis of cause-specific mortality in Kenya and South Africa using health and demographic surveillance data

Awareness and outcomes of the fruits and veggies (FNV) campaign to promote fruit and vegetable consumption among targeted audiences in California and Virginia: a cross-sectional study

Epidemiological features of hypertension among ischemic survivors in Northeast China: insights from a population-based study, 2017–2019

Reproductive intentions and corresponding use of safer conception methods and contraception among Ugandan HIV clients in serodiscordant relationships

Forecasting the incidence of mumps in Chongqing based on a SARIMA model